Coronary artery atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants were enrolled if they fulfilled the following criteria: men or women between 18 and 65 years, meet Western diagnostic criteria for coronary artery disease with significant anxiety symptoms (HAMA score of 14-21; 50 points = SAS score of 50-69), and signed the informed consent paper.
Exclusion criteria
Exclusion criteria: Patients with any of the following conditions were excluded: acute myocardial infarction; unstable angina pectoris; other heart disease or severe cardiac insufficiency (American New York Heart Association cardiac function class > Class III); poorly controlled hypertension after standard treatment (blood pressure >170/105 mm Hg); primary diseases of the brain, liver, kidney and hematopoietic systems; serious mental illness with hallucinations, delusions, panic attacks, and suicidal behavior; menopausal syndrome, neurosis, hyperthyroidism; pregnant and lactating women; involvement in other clinical trials within the previous three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety Symptom Rating; | — |
Countries
China